{"filing":{"accession_number":"0001932393-26-000045","cik":"0001932393","ticker":"GEHC","company_name":"GE HealthCare Technologies Inc.","form":"8-K","filing_date":"2026-07-29","report_date":"2026-07-29","primary_document":"gehc-20260729.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1932393/000193239326000045/gehc-20260729.htm"},"events":[{"id":21324,"run_id":19229,"accession_number":"0001932393-26-000045","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"GE HealthCare issued a press release on July 29, 2026 announcing its second quarter 2026 financial results, including revenues of $5.3 billion (up 5.7%), net income of $561 million, diluted EPS of $1.24 (up 16.5%), and reaffirmed full-year 2026 guidance. The disclosure is a standard quarterly earnings announcement furnished as Exhibit 99 under Item 2.02, with detailed financial statements and segment performance data.","company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","filing_date":"2026-07-29","form":"8-K","submitted_at":null,"items":[{"id":20943,"accession_number":"0001932393-26-000045","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"GE HealthCare issued a press release on July 29, 2026 announcing its second quarter 2026 financial results, including revenues of $5.3 billion (up 5.7%), net income of $561 million, diluted EPS of $1.24 (up 16.5%), and reaffirmed full-year 2026 guidance. The disclosure is a standard quarterly earnings announcement furnished as Exhibit 99 under Item 2.02, with detailed financial statements and segment performance data.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T10:26:40.433653+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20943,"accession_number":"0001932393-26-000045","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"GE HealthCare issued a press release on July 29, 2026 announcing its second quarter 2026 financial results, including revenues of $5.3 billion (up 5.7%), net income of $561 million, diluted EPS of $1.24 (up 16.5%), and reaffirmed full-year 2026 guidance. The disclosure is a standard quarterly earnings announcement furnished as Exhibit 99 under Item 2.02, with detailed financial statements and segment performance data.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T10:26:40.433653+00:00","company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","filing_date":"2026-07-29"}]}